These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13856129)

  • 21. Preparation and inactivation of purified poliovirus: comparison of vaccines derived from Mahoney and Parker poliovirus.
    CHARNEY J; FISHER WP; MACHLOWITZ RA
    Proc Soc Exp Biol Med; 1957 Dec; 96(3):601-5. PubMed ID: 13505802
    [No Abstract]   [Full Text] [Related]  

  • 22. [ISOLATION OF THE VIRUS AND DETECTION OF NEUTRALIZING ANTIBODIES AT THE TIME OF THE REGIONAL EPIDEMIC OF POLIOMYELITIS IN 1963].
    ENJALBERT L; GENARD M; LARENG MB; DIDIER J
    J Med Bord; 1964 Nov; 141():1657-64. PubMed ID: 14230065
    [No Abstract]   [Full Text] [Related]  

  • 23. The safety test for poliomyelitis vaccine. III. Comparative sensitivity of rhesus and vervet monkeys to poliovirus.
    VAN HOOSIER GL; BARON S; KIRSCHSTEIN RL; ABINANTI FR
    Am J Hyg; 1962 Jan; 75():86-9. PubMed ID: 13924586
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of 0.1 ml whole blood samples for testing neutralizing antibodies against poliovirus.
    LUND E
    Arch Gesamte Virusforsch; 1958; 8(1):131-8. PubMed ID: 13534321
    [No Abstract]   [Full Text] [Related]  

  • 25. A survey of poliovirus neutralizing antibody in Newfoundland, 1959-60.
    OZERE RL; ROZEE KR
    Can Med Assoc J; 1961 Jul; 85(2):63-7. PubMed ID: 13731845
    [No Abstract]   [Full Text] [Related]  

  • 26. [Viral excretion after mass vaccination with attenuated polio virus in Hungary].
    DOEMOEK J; MOLNAR E; JANCSO A
    Offentl Gesundheitsdienst; 1961 Oct; 23():504-6. PubMed ID: 13886900
    [No Abstract]   [Full Text] [Related]  

  • 27. Detecting poliovirus in vaccine lots used in Idaho in 1955.
    EKLUND CM; HADLOW WJ; PICKENS EG; GERLOFF RK
    Public Health Rep (1896); 1959 Jan; 74(1):60-6. PubMed ID: 13623976
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibodies against poliovirus in vaccinated and unvaccinated children in an epidemic area.
    BOISSARD GP
    Lancet; 1958 Jun; 1(7034):1326-8. PubMed ID: 13551000
    [No Abstract]   [Full Text] [Related]  

  • 29. A simple method for concentration of live and formaldehyde-inactivated poliovirus.
    GROSSOWICZ N; MERCADO A; GOLDBLUM N
    Proc Soc Exp Biol Med; 1960 Apr; 103():872-4. PubMed ID: 13829716
    [No Abstract]   [Full Text] [Related]  

  • 30. Complement-fixing antigens of living and inactivated poliovirus. II. Complement-fixing activity of poliomyelitis vaccine and its relation to immunogenic potency.
    WARREN J; HARE JD; GOLDMAN C
    Am J Public Health Nations Health; 1959 Jan; 49(1):53-61. PubMed ID: 13617534
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibitory effects of passive antibody on virulent poliovirus excretion and on immune response in chimpanzees.
    BODIAN D; NATHANSON N
    Bull Johns Hopkins Hosp; 1960 Sep; 107():143-62. PubMed ID: 13801930
    [No Abstract]   [Full Text] [Related]  

  • 32. [The present status of poliomyelitis inoculation with live avirulent polio virus. Report from an information tour].
    BUSER F
    Schweiz Med Wochenschr; 1960 Jan; 90():44-7. PubMed ID: 13806390
    [No Abstract]   [Full Text] [Related]  

  • 33. Complement-fixing antigens of live and inactivated poliovirus. III. Evaluation of a sensitive quantitative procedure for complement fixation.
    HARE JD; WARREN J
    Am J Hyg; 1958 Nov; 68(3):312-21. PubMed ID: 13594931
    [No Abstract]   [Full Text] [Related]  

  • 34. A phase contrast microprecipitin test with poliovirus antigens. II. Occurrence and development of microprecipitin antibody after natural inapparent infections, after inoculation of Salk vaccine, after feeding of attenuated live poliovirus vaccine, and in disease caused by polioviruses and other enteroviruses.
    EGGERS HJ; SABIN AB
    Arch Gesamte Virusforsch; 1961; 11():152-75. PubMed ID: 13725917
    [No Abstract]   [Full Text] [Related]  

  • 35. Community-wide type 3 oral poliovirus vaccination in Atlanta, Ga., 1961. Medical and virologic results of an epidemic prevention program.
    GELFAND HM; HOLGUIN AH; FELDMAN RA
    JAMA; 1962 Jul; 181():281-9. PubMed ID: 13897588
    [No Abstract]   [Full Text] [Related]  

  • 36. THE REDUCTION OF WILD POLIOVIRUS CIRCULATION FOLLOWING VACCINATION WITH THE LIVE VACCINE. A NEW FACTOR IN THE OECOLOGY OF ENTERIC VIRUSES?
    PESEK J; VOBECKY J
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():262-3. PubMed ID: 14184882
    [No Abstract]   [Full Text] [Related]  

  • 37. The presence of circulating antibodies to polio virus in a small series of Northern Rhodesia Africans.
    TAUBE E
    Cent Afr J Med; 1960 Oct; 6():421-2. PubMed ID: 13775474
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antibody response to a vaccination against polio virus during treatment with isonicotinic acid hydrazide].
    PITZURRA M; CUSMA N; BISCATTI O; DONATI M
    Boll Soc Ital Biol Sper; 1962 Feb; 38():130-2. PubMed ID: 14487009
    [No Abstract]   [Full Text] [Related]  

  • 39. Vaccination with the CHAT strain of type 1 attenuated poliomyelitis virus in Leopoldville. Belgian Congo. 2. Studies of the safety and efficacy of vaccination.
    PLOTKIN SA; LEBRUN A; KOPROWSKI H
    Bull World Health Organ; 1960; 22(3-4):215-34. PubMed ID: 14433516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EXPERIENCE IN THE ADMINISTRATION OF LIVE ATTENUATED POLIOVIRUS VACCINE (SABIN) IN INFANTS, WITH REFERENCE TO THE RELATION BETWEEN POLIO AND NON-POLIO VIRUSES.
    KONISHI S; SASATANI M; HAYAKAWA Y; KUROSE T; ASHIHARA Y
    Shonika Kiyo; 1963; 9():283-96. PubMed ID: 14112921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.